# Olanzapine Treatment of Patients With Bipolar I Disorder

> **NCT00510146** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 514 (actual)

## Conditions studied

- Depression, Bipolar

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00510146
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-07
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2011-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510146, "Olanzapine Treatment of Patients With Bipolar I Disorder". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00510146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*